243706 ⎘
Nanotechnology; Specified use of nanostructure for medical, immunological, body treatment, or diagnosis Immunological
Magnetic-nanoparticle Conjugates and Methods of Use
#2Carbon nanotube compositions and methods of use thereof
#3Labelled silica nanoparticles for immunochromatographic reagent, immunochromatographic test strip using the same, and immunochromomatographic fluorescence-detecting system or radiation-detecting system
#4Immunologically modified carbon nanotubes for cancer treatment
#5Immunologically modified carbon nanotubes for cancer treatment
#6Signal enhancement system with multiple labeled-moieties
#7LABELLED SILICA NANOPARTICLES FOR IMMUNOCHROMATOGRAPHIC REAGENT, IMMUNOCHROMATOGRAPHIC REAGENT, IMMUNOCHROMATOGRAPHIC TEST STRIP USING THE SAME, AND IMMUNOCHROMATOGRAPHIC FLUORESCENCE-DETECTING SYSTEM OR RADIATION-DETECTING SYSTEM
#8Magnetic-nanoparticle conjugates and methods of use
#9Magnetic-nanoparticle conjugates and methods of use
#10Eukaryotic layered vector initiation systems
#11ADJUVANT FORMULATION COMPRISING A SUBMICRON OIL DROPLET EMULSION
#12Environmental sampling and testing method
#13Immunological control of beta-amyloid levels in vivo
#14Magnetic-nanoparticle conjugates and methods of use
#15Labelled silica nanoparticles for immunochromatographic assays
#16Hepatitis C virus asialoglycoproteins
#17Cationic liposomes containing immune response generating moieties
#18Signal enhancement system with multiple labeled-moieties
#19Environmental sampling and testing device
#20Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#21Self-assembling recombinant papillomavirus capsid proteins
#22Immunological control of beta-amyloid levels in vivo
#23Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
#24Immunological control of β-amyloid levels in vivo
#25Methods and compositions for inducing autoimmunity in the treatment of cancers
#26Antibodies to hepatitis C virus asialoglycoproteins